anmelden
Analysen von James Gordon
| 17.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 13.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 12.02.26 | Sanofi Equal Weight | Barclays Capital | |
| 11.02.26 | AstraZeneca Overweight | Barclays Capital | |
| 10.02.26 | AstraZeneca Overweight | Barclays Capital | |
| 10.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 10.02.26 | Roche Overweight | Barclays Capital | |
| 09.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
|
Werbung
|
|||
| 09.02.26 | Roche Overweight | Barclays Capital | |
| 03.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 30.01.26 | Roche Overweight | Barclays Capital | |
| 27.01.26 | Roche Overweight | Barclays Capital | |
| 23.01.26 | Sanofi Equal Weight | Barclays Capital | |
| 22.01.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 20.01.26 | GSK Underweight | Barclays Capital | |
| 20.01.26 | Bayer Overweight | Barclays Capital | |
| 15.01.26 | AstraZeneca Overweight | Barclays Capital | |
| 15.01.26 | GSK Underweight | Barclays Capital | |
| 15.01.26 | Novartis Equal Weight | Barclays Capital | |
| 15.01.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 15.01.26 | Roche Overweight | Barclays Capital | |
| 15.01.26 | Sanofi Equal Weight | Barclays Capital | |
| 07.01.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 07.01.26 | AstraZeneca Overweight | Barclays Capital | |
| 07.01.26 | Sanofi Equal Weight | Barclays Capital | |
| 07.01.26 | GSK Underweight | Barclays Capital | |
| 07.01.26 | Novartis Equal Weight | Barclays Capital | |
| 07.01.26 | Roche Overweight | Barclays Capital | |
| 02.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.06.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 24.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.06.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 03.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.04.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 28.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 22.04.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 26.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.03.25 | Lufthansa Underweight | JP Morgan Chase & Co. | |
| 26.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 19.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
